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Insomnia, defined as difficulty falling asleep, staying asleep or waking up too early for 3 or 
more nights per week for 3 months or more with significant daytime effects (1) is the most 
common sleep problem presenting in general practice: 10 to 12% of the population meet 
formal diagnostic criteria for insomnia disorder, and up to 40% express complaints of 
insomnia (2). 
 
For those suffering from sleep problems, the general practitioner (GP) is often the first point 
of contact with previous research suggesting 79% of GPs see someone with a sleep 
complaint at least once a week (3). GPs are often unaware of patients’ sleep problems, and 
even when they are, fewer than 8% of doctors use validated sleep questionnaires or sleep 
diaries (4). Despite both GPs and patients believing that a detailed sleep assessment is 
important, this lack of assessment may be due to time pressures and/or a limited 
knowledge of how best to evaluate sleep complaints (5).  
 
For these reasons, a brief measure that can reliably screen for insomnia could be invaluable. 
The two-item Sleep Condition Indicator (SCI-02) has been developed to help GPs and 
primary care nurses screen for insomnia (6) (Figure 1). The two items derived from the full, 
validated 8-item Sleep Condition Indicator (SCI) (6), also available in Chinese, French, Italian 
and Romanian, include questions reflecting being troubled about sleep problems and the 
duration of the sleep complaint, and have been suggested for a short version based on their 
high predicted value (82% variance) of the full scale SCI (6). 
 
Each item is scored on a 5-point scale (0 – 4), with lower scores, in the 0 – 2 range, reflecting 
DSM-5 threshold criteria for Insomnia Disorder and sleep being in relatively poor condition. 
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Possible total scores ranges from 0 – 8, with higher values indicative of better sleep (that is 
sleep being in better condition). To facilitate use within clinical practice reference values are 
available for different sex and age groups.  
 
We have validated the SCI-02 using a sample of 200,000 persons who completed it online, 
randomly extracted from an online platform or mobile app (www.sleepio.com), similar to a 
previous validation of the full SCI (7). By completing the measures online participants agreed 
that their data could be used anonymously for research. A subsample of participants also 
completed the remaining questions of the full SCI within one hour allowing us to assess the 
correlation between the SCI-02 and the full SCI.  
 
The sample of 200,000 adults had a mean age of 40.24 ± 14.31 years and comprised 105,839 
women (55.7%).  Cronbach’s α and the Spearman-Brown’s correlation, suggested to be a 
better indicator of reliability for two item-measures, for the entire sample were both 
acceptable at 0.74 (8).  The test-retest reliability and intraclass correlation coefficient in a 
sample repeating the test from 12 hours up to 7 days were r = 0.680 and ICC = 0.680 
respectively.  
 
In a subsample of 4,612 users (age: 41 ± 12; 57% female) who completed both the SCI-02 
and the remaining 6 items of the full SCI within 1 hour, the SCI-02 was correlated strongly 
(r=0.80) with the total score of the full SCI. A cut-off of ≤2 for the SCI-02 predicted those 
identified with probable insomnia according to the full SCI with a specificity of 80% and 
sensitivity of 79%. Some caution is needed as the sample was self-selected, thus likely to be 
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in favour of those who had an interest in sleep, and a bias towards those with a sleep 
problem. 
 
The ultra-short, two-item version of the Sleep Condition Indicator can be used to rapidly 
screen for insomnia in routine clinical practice, asking about being troubled by sleep and the 
duration of the complaints, with a SCI-02 score of 2 or less indicating insomnia (Figure 1). 
The GP could then assess the insomnia complaint further by administering the remaining 6 
items of the SCI and can also compare the patients’ score to the reference values presented 
in Table 1 to facilitate clinical interpretation.   
 
In conclusion, ultrashort instruments such as the SCI-02 could help GPs and nurses to 
routinely assess potential sleep problems in their patients, accurately, reliably and quickly. 
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Figure 1 Two-item version of the Sleep Condition Indicator (SCI-02) 
 
Scoring instructions: 
a. Add the item scores to obtain the SCI total (minimum 0, maximum 8) 
b. A higher score means better sleep 
  
 
 
 
  
 Score 
Item 4 3 2 1 0 
Thinking about the past month, to what extent has poor sleep … 
1. … troubled you in general Not at all A little Somewhat Much Very much 
Thinking about a typical night in the last 
month …  
     
2. … how many nights a week do you 
have a problem with your sleep? 
0 - 1 2 3 4 5 - 7 
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Table 1 Two-item version of Sleep Condition Indicator (SCI-2) sex and age-related reference values, N=200,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F: female; M: male; SD: standard deviation; IQR: interquartile range. 
Range SCI 0-8 with 8 indicating better sleep. 
 
Age group (years) Sex N Mean (SD) Median (IQR) 
16 – 25 F 
M 
17,526 
14,450 
2.76 (2.24) 
3.19 (2.33) 
2 (1-4) 
3 (1-5) 
26 – 35 F 
M 
26,509 
25,833 
2.95 (2.28) 
3.35 (2.31) 
3 (1-5) 
3 (1-5) 
36 – 45 F 
M 
19,342 
17,748 
2.38 (2.16) 
2.85 (2.24) 
2 (1-4) 
2 (1-4)  
46 – 55 F 
M 
21,123 
13,431 
2.01 (2.01) 
2.42 (2.16) 
2 (0-3) 
2 (1-4) 
56 – 65 F 
M 
15,689 
8.868 
1.86 (1.92) 
2.22 (2.06) 
1 (0-3) 
2 (1-3) 
66 – 75 F 
M 
5,650 
3,831 
1.46 (1.63) 
1.75 (1.75) 
1 (0-2) 
1 (0-2) 
All ages F 
M 
105,839 
84,161 
2.39 (2.17) 
2.88 (2.28) 
2 (1-4) 
2 (1-4) 
 All 200,000 2.60 (2.23) 2 (1-4) 
